Analyst stock forecast
Allogene Therapeutics, Inc. - Common Stock Stock Forecast and Analyst Price Target
ALLO analyst target range, upside, consensus rating and coverage count.
Direct answer
Allogene Therapeutics, Inc. - Common Stock's average price target is $9.00.
The target implies +373.7% from the recorded current price, and the consensus rating is Strong Buy.
The verified range is $4.00 to $14.00, with 9 analysts in the current consensus when available.
Forecast evidence checked August 4, 2026.
Verified data
- Current price
- $1.90
- Average price target
- $9.00
- High price target
- $14.00
- Low price target
- $4.00
- Target upside
- +373.7%
- Consensus rating
- Strong Buy
- Analysts
- 9
- Evidence date
- August 4, 2026
- Valid through
- August 11, 2026